We analyzed mutations of 7 vitamin K-dependent protein and cytochrome P450 2C9 genes in 45 patients and investigated whether any contribute to the large interpatient variability in the warfarin dose-effect relationship. Total clearance and daily dose, INR and INR/Cp, were used as pharmacokinetic and pharmacodynamic indexes, respectively. Patients were grouped by genotype based on a single polymorphism and combinations of polymorphisms. Among the 30 sequence variants identified, CYP2C9*3, 165Thr-->Met of the factor II gene, -402G-->A, (37-bp repeat)n, and -746T-->C of the factor VII gene, and (CAA repeat)n of the gamma-glutamyl carboxylase gene were selected as candidate polymorphisms. As the analysis of single polymorphisms implied, the highest INR/Cp mean values and the lowest warfarin maintenance doses were observed in patients homozygous for the 165Met, -402G, (37-bp repeat)6 and -746T alleles. Multiple regression analysis revealed that warfarin sensitivity was independently associated with -402G-->A, (CAA repeat)n, CYP2C9*3, and 165Thr-->Met, which accounted for 50% of variance. These results suggest that part of the considerable interpatient variation is attributable to genetic variation, and the combined genotyping of CYP2C9 and certain vitamin K-dependent protein genes is useful for predicting anticoagulant responses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2003-09-3043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of gamma-glutamyl carboxylase activity in its native milieu.
Methods Enzymol
November 2024
Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address:
Gamma-glutamyl carboxylase (GGCX), a polytopic membrane protein found in the endoplasmic reticulum, catalyzes the posttranslational modification of a variety of vitamin K-dependent (VKD) proteins to their functional forms. GGCX uses the free energy from the oxygenation of reduced vitamin K to remove the proton from the glutamate residue to drive VKD carboxylation. During the process of carboxylation, reduced vitamin K is oxidized to vitamin K epoxide.
View Article and Find Full Text PDFCellular and biochemical approaches to define GGCX carboxylation of vitamin K-dependent proteins.
Methods Enzymol
November 2024
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland, OH, United States.
Article Synopsis
- Gamma-glutamyl carboxylase (GGCX) is crucial for modifying vitamin K-dependent proteins by adding carboxyl groups, which is essential for their functions in blood clotting and bone health.
- Mutations in GGCX can lead to diseases such as vitamin K clotting factor deficiency and pseudoxanthoma elasticum-like diseases, but the mechanisms behind these mutations are not fully understood.
- This chapter discusses biochemical and cellular methods used to study GGCX's function and the impact of its mutations, highlighting the need for a balanced presence of various components and methodologies to fully understand the enzyme's activity.
Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K-Dependent Coagulation Factors Deficiency.
Semin Thromb Hemost
November 2024
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
Vitamin K-dependent coagulation factors deficiency (VKCFD) is a rare autosomal recessive genetic disease characterized by impaired levels of multiple coagulation factors (II, VII, IX, and X) and natural anticoagulants (proteins C and S). VKCFD is part of familial multiple coagulation factor deficiencies, reporting overall 50 affected families thus far. Disease manifestations are quite heterogeneous, bleeding symptoms may vary, and even, although generally mild, some patients may succumb to fatal outcomes.
View Article and Find Full Text PDFInorganic pyrophosphate plasma levels in patients with GGCX-associated PXE-like phenotypes.
Front Genet
September 2024
PXE International, Inc., Damascus, MD, United States.
Article Synopsis
- - Pseudoxanthoma elasticum (PXE) is a genetic disorder affecting skin, eyes, and blood vessels, mainly caused by mutations in the ABCC6 gene that lead to impaired calcium regulation in the body.
- - The study examined five patients from unrelated families with biallelic variants in the GGCX gene, associated with PXE-like symptoms, using next-generation sequencing for diagnosis.
- - Findings indicate that GGCX variants can also cause PXE characteristics and that patients' plasma levels of inorganic pyrophosphate (PPi) remain normal, challenging the idea that PPi levels are responsible for ectopic calcification in GGCX deficiency.
Pseudoxanthoma Elasticum-Like Changes:Associations- and Underlying Mechanisms.
Skinmed
August 2024
Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon;
Article Synopsis
- * The condition usually appears during the teenage years and is primarily caused by mutations in specific genes, with most cases being sporadic or recessive.
- * Recent research has identified several disorders that display PXE-like symptoms or microscopic features, prompting a discussion on the potential mechanisms that could cause this overlap.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!